Send to

Choose Destination
See comment in PubMed Commons below
Antimicrob Agents Chemother. 2007 Nov;51(11):4202-4. Epub 2007 Aug 20.

In vitro antimycobacterial spectrum of a diarylquinoline ATP synthase inhibitor.

Author information

  • 1Department of Bacteriology, Swedish Institute for Infectious Disease Control, S-171 82 Solna, Sweden.


The diarylquinoline R207910 is in clinical development for tuberculosis treatment. The MIC(50) for 41 drug-susceptible and 44 multidrug-resistant Mycobacterium tuberculosis clinical isolates was 0.032 microg/ml. Out of 20 additional mycobacterial species, three were found to be naturally resistant to R207910 and were shown to exhibit a polymorphism in their atpE genes.

[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk